CAMBRIDGE, England–(BUSINESS WIRE)–TTP Ventus Ltd, a spin-out from TTP plc, created to bring disruptive new micropump technologies to market, has announced that Sommetrics Inc., is using its Disc Pump technology to enable aerSleep™, a novel negative-pressure system for the treatment of obstructive sleep apnea (OSA). Having recently received a Health Canada Medical Device License, aerSleep is now approved for marketing to patients in Canada. CE mark approval is expected Q4 2018.
OSA is a disorder characterised by airway collapse during sleep, causing sufferers to stop breathing temporarily. The muscles supporting soft tissues in the throat relax, allowing the tissues to close over and obstruct the airway. It is estimated that there are more than 100 million sufferers worldwide, with more than 22 million in the United States alone. The leading conventional treatment for OSA is continuous positive airway pressure (CPAP). The treatment is effective yet requires users to wear a face mask connected via a hose to a large bedside pump unit, which is often uncomfortable, disruptive, and can restrict users’ movement during sleep.